Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report) shares rose 12.8% on Friday . The stock traded as high as $2.04 and last traded at $2.0299. Approximately 920 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 9,115 shares. The stock had previously closed at $1.80.
Silence Therapeutics Stock Up 12.8%
The stock has a 50 day moving average of $1.70 and a 200-day moving average of $1.62.
About Silence Therapeutics
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Read More
- Five stocks we like better than Silence Therapeutics
- What is a Stock Market Index and How Do You Use Them?
- 3 Finance Stocks to Buy on Rising 10-Year Treasury Rates
- Ride Out The Recession With These Dividend Kings
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Why Amazon Could Be a $300 Stock Within Weeks
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
